Tethys Bioscience is dedicated to the discovery, development and commercialization of novel biological markers, Biomarkers, directed at the broad use of these markers in clinical practice. Our focus is in areas where significant numbers of individuals may potentially benefit from the knowledge derived from tests that indicate that they are at risk of developing certain conditions. In the cases where patients are receiving treatment, our biomarkers may be used to monitor progress of treatment strategies over time. Tethys Bioscience is unique in its approach in that it does not rely on a single technology platform to solve research challenges, but instead uses the best technologies available to address the respective clinical need, depending on the clinical and scientific needs.